Aveva Drug Delivery Systems
Aveva Drug Delivery Systems (United States) has no DMF, CEP or site registration linked in our records. 44 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Aveva Drug Delivery Systems: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/aveva-drug-delivery-systems
Overview
Aveva Drug Delivery Systems is a pharmaceutical company headquartered in Miramar, United States.
FDA compliance signals
44 FDA enforcement records linked to this company.
- 4832026-08-14
Systems in place to comply with verification requirements
- 4832026-08-14
Procedures not in writing, fully followed
- 4832026-08-14
Identity Testing of Each Component
- recall — Class III2026-06-03
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
- 4832023-09-01
Label storage access limited to authorized personnel
- 4832023-09-01
Washing and toilet facilities are deficient
- recall — Class III2023-03-22
Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
- recall — Class III2023-03-22
Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
- 4832018-04-27
Items to cover on annual reviews
- 4832018-04-27
Computer control of master formula records
- 4832018-04-27
Investigations made into any unexplained discrepancy
- 4832018-04-27
Complaint Handling Procedure
- 4832018-04-27
Control procedures to monitor and validate performance
- 4832018-04-27
Changes to Procedures Not Reviewed, Approved
- 4832014-04-11
Computer control of master formula records
- 4832014-04-11
Procedures are written, and followed
- 4832014-04-11
Procedure Deviations Recorded and Justified
- 4832014-04-11
Written procedures not established/followed
- 4832014-04-11
Items to cover on annual reviews
- 4832014-04-11
Training , Education , Experience overall
- 4832014-04-11
Calibration - at intervals, written program, remedial action
- 4832011-09-28
Written Procedures Not Followed
- 4832011-09-28
Calibration - at intervals, written program, remedial action
- 4832011-09-28
Review of representative number of batches
- 4832011-09-28
Acceptance criteria for sampling & testing
- 4832011-09-28
Procedures not in writing, fully followed
- 4832011-09-28
Investigations of discrepancies, failures
- 4832011-09-28
input/output verification
- warning_letter2010-05-21
FDA Warning Letter (drug product)
- 4832009-12-04
Examination of issued labels
- 4832009-12-04
Procedures to be written and followed
- 4832009-12-04
Accelerated stability studies
- 4832009-12-04
Rejecting When Specifications Not Met
- 4832009-12-04
input/output verification
- 4832009-12-04
Written in-process control procedures
- 4832009-12-04
Extent of discrepancy, failure investigations
- 4832009-12-04
Investigations of discrepancies, failures
- 4832009-12-04
Procedures not in writing, fully followed
- 4832009-12-04
Theoretical yield statement including percentages
- 4832009-12-04
Quality control unit review of records
- 4832009-12-04
Changes to Procedures Not Reviewed, Approved
- 4832009-12-04
Packaging line inspection after use
- 4832009-12-04
Written Procedures Not Followed
- 4832009-12-04
Training , Education , Experience overall
Is this Aveva Drug Delivery Systems?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.